There are 2949 resources available
Summary and meeting close
Presenter: Neal Shore
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Welcome and introduction
Presenter: Cristina Suarez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Shifting perceptions in the first-line treatment of aRCC & Panel discussion
Presenter: Toni Choueiri
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Personalizing treatment approaches in clinical practice. Part 1: Sequencing of treatment in aRCC following progression & Panel discussion
Presenter: Camillo Guglielmo Porta
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Personalizing treatment approaches in clinical practice. Part 2: Understanding the patient experience of aRCC & Panel discussion
Presenter: Howard Gurney
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Closing comments
Presenter: Cristina Suarez Rodriguez
Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion
Resources:
Webcast
Exploring the emerging research with immuno-oncology in CSCC
Presenter: Dirk Schadendorf
Session: Sanofi Genzyme - Immune checkpoint blockade in non-melanoma skin cancer
Resources:
Webcast
Broadening horizons: new data and combinations with PARP inhibitors
Presenter: Isabelle Ray-Coquard
Session: AstraZeneca - Redefining long-term outcomes in the era of personalised medicine: Maintenance treatment in newly diagnosed ovarian cancer
Resources:
Webcast
Live Q&A - 28 September 2020 - 17:00-17:30
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast